<DOC>
	<DOCNO>NCT00380484</DOCNO>
	<brief_summary>The purpose study assess treatment budesonide 200 microgram per day affect short- long term growth child asthma</brief_summary>
	<brief_title>Short- Long Term Growth Children With Asthma</brief_title>
	<detailed_description>When child asthma treat inhaled corticosteroid risk systemic adverse event growth suppression . It report treatment budesonide 200 microgram per day affect short term growth child asthma . The aim present study ass unaffected short term growth mean also long term growth unaffected . Short long term growth asthmatic child treat budesonide compare growth asthmatic child treat montelukast .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>age 611 , prepubertal , asthma , normal weight height , informed consent treatment systemic/inhaled/intranasal corticosteroid within last week , major surgery within 4 week , usage drug significantly inhibit CYP3A4</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>